Graft Reactions in Organ Transplant Patients Which of the following best describes hyperacute rejection?

Brief Introduction: Hyperacute rejection is a Type II hypersensitivity response characterized by thrombotic occlusion of the graft vasculature. This rapid immunological attack occurs when the recipient possesses preformed antibodies against donor human leukocyte antigens (HLA) or ABO blood group antigens, leading to immediate complement activation and irreversible graft necrosis. Rationale: A. Gradual organ dysfunction due to ischemia is characteristic of chronic rejection rather than the hyperacute phase. While chronic ischemia leads to graft failure over time, hyperacute reactions are defined by a sudden cessation of blood flow and immediate macroscopic changes in the organ's appearance during the surgical procedure. B. Rejection occurring days to weeks post-transplant is typically classified as acute rejection. While fibrosis is a long-term consequence, this timeframe involves cellular infiltration rather than the antibody-mediated rapid destruction. Hyperacute rejection is too fast for organ fibrosis to develop, as the tissue dies within hours. C. Hyperacute rejection occurs within minutes to hours because the recipient's immune system already contains antibodies that recognize the donor tissue. This results in hemorrhagic necrosis, requiring the immediate surgical removal of the transplanted organ to prevent a systemic inflammatory response. D. Mediated by T-cells and occurring months to years later, this description fits chronic rejection. Hyperacute rejection is primarily B-cell and antibody-mediated, whereas chronic rejection involves a slow, progressive immune response that results in the gradual obliteration of vasculature and replacement of functional tissue with scar tissue.